Get the Stockscreener App
17.37
4.82%
-0.88
After Hours:
17.90
0.53
+3.05%
Eton Pharmaceuticals Inc Stock (ETON) Latest News
FDA extends target action date for Eton's ET-400 - MSN
Eton Pharmaceuticals Says ET-400 FDA Decision Delayed to May -February 06, 2025 at 10:15 am EST - Marketscreener.com
Eton Pharmaceuticals : FDA Extends ET-400 Review to Late May -February 06, 2025 at 08:37 am EST - Marketscreener.com
Eton Pharmaceuticals: FDA Extends ET-400 Review to Late May - MarketWatch
Eton Pharmaceuticals: FDA extends PDUFA date for NDA for ET-400 to 5/28 - TipRanks
Eton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400 - GlobeNewswire
Eton's Pediatric Rare Disease Drug Faces 3-Month FDA Review ExtensionRevenue Outlook Unchanged - StockTitan
Baader Bank Aktiengesellschaft Takes $373,000 Position in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - MarketBeat
Eton Pharmaceuticals Stock Hits All-Time High of $17.57 - MSN
Eton Pharmaceuticals Stock Hits All-Time High of $17.57 By Investing.com - Investing.com Nigeria
Here's What Could Help Eton Pharmaceuticals (ETON) Maintain Its Recent Price Strength - Yahoo Finance
Q2 EPS Estimate for Eton Pharmaceuticals Raised by Analyst - Defense World
Q2 EPS Estimate for Eton Pharmaceuticals Lifted by Analyst - MarketBeat
Eton Pharmaceuticals price target raised to $23 from $18 at Craig-Hallum - Yahoo Finance
Strength Seen in Eton Pharmaceuticals (ETON): Can Its 10.8% Jump Turn into More Strength? - MSN
HC Wainwright Has Negative Outlook for ETON Q1 Earnings - Defense World
Q1 EPS Forecast for Eton Pharmaceuticals Lowered by Analyst - MarketBeat
Westside Investment Management Inc. Sells 43,453 Shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - MarketBeat
HC Wainwright Issues Positive Forecast for Eton Pharmaceuticals (NASDAQ:ETON) Stock Price - MarketBeat
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) On The Verge Of Breaking Even - Simply Wall St
Eton Pharmaceuticals stock soars to all-time high of $15.11 - MSN
Eton Pharmaceuticals stock soars to all-time high of $15.11 By Investing.com - Investing.com Australia
Eton acquires Wilson disease drug Galzin - MSN
14 Best 52-Week High Stocks To Buy According to Analysts - Insider Monkey
Eton Pharmaceuticals, Inc. (ETON): Analysts Recommend This 52-Week High Stocks Now - Insider Monkey
15,006 Shares in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Acquired by Jane Street Group LLC - Defense World
Q1 Earnings Estimate for ETON Issued By B. Riley - Defense World
Q1 Earnings Forecast for ETON Issued By B. Riley - MarketBeat
Eton Pharmaceuticals (NASDAQ:ETON) Upgraded at B. Riley - Defense World
Eton Pharmaceuticals (NASDAQ:ETON) Coverage Initiated at B. Riley - Defense World
Eton Pharmaceuticals (NASDAQ:ETON) Raised to "Strong-Buy" at B. Riley - MarketBeat
When the Price of (ETON) Talks, People Listen - news.stocktradersdaily.com
B. Riley Begins Coverage on Eton Pharmaceuticals (NASDAQ:ETON) - MarketBeat
Craig Hallum Forecasts Strong Price Appreciation for Eton Pharmaceuticals (NASDAQ:ETON) Stock - Defense World
HC Wainwright Issues Positive Forecast for ETON Earnings - Defense World
Investing in Eton Pharmaceuticals (NASDAQ:ETON) three years ago would have delivered you a 177% gain - Yahoo Finance
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Position Boosted by Geode Capital Management LLC - Defense World
What is HC Wainwright’s Forecast for ETON FY2027 Earnings? - Defense World
Eton Pharmaceuticals’ Acquisition of Galzin® - Global Legal Chronicle
Eton Pharmaceuticals (NASDAQ:ETON) Price Target Raised to $18.00 at Craig Hallum - MarketBeat
The Analyst Verdict: Eton Pharmaceuticals In The Eyes Of 5 Experts - Benzinga
What is HC Wainwright's Forecast for ETON FY2027 Earnings? - MarketBeat
Eton Pharmaceuticals (NASDAQ:ETON) Price Target Raised to $17.00 - MarketBeat
Morrison Foerster counsels pharma company on acquisition of treatment drug Galzin® - ICLG.com
Eton Pharmaceuticals (NASDAQ:ETON) versus Repare Therapeutics (NASDAQ:RPTX) Financial Survey - Defense World
Eton Pharmaceuticals Acquires FDA-Approved Zinc Treatment for Wilson Disease - Defense World
0.25%
0.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):